Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma
B Lanier, T Bridges, M Kulus, AF Taylor… - Journal of Allergy and …, 2009 - Elsevier
BACKGROUND: Many children with asthma continue to experience symptoms despite
available therapies. OBJECTIVE: This study evaluated the efficacy and safety of …
available therapies. OBJECTIVE: This study evaluated the efficacy and safety of …
[引用][C] Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma
B Lanier, T Bridges, M Kulus, AF Taylor… - Journal of Allergy and …, 2009 - cir.nii.ac.jp
Omalizumab for the treatment of exacerbations in children with inadequately controlled
allergic (IgE-mediated) asthma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
allergic (IgE-mediated) asthma | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma
B Lanier, T Bridges, M Kulus, AF Taylor… - Journal of Allergy and …, 2009 - jacionline.org
Background Many children with asthma continue to experience symptoms despite available
therapies. Objective This study evaluated the efficacy and safety of omalizumab, a …
therapies. Objective This study evaluated the efficacy and safety of omalizumab, a …
Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma
B Lanier, T Bridges, M Kulus, AF Taylor, I Berhane… - 2009 - pubmed.ncbi.nlm.nih.gov
Background Many children with asthma continue to experience symptoms despite available
therapies. Objective This study evaluated the efficacy and safety of omalizumab, a …
therapies. Objective This study evaluated the efficacy and safety of omalizumab, a …
[引用][C] Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma
B LANIER, T BRIDGES, M KULUS… - Journal of allergy …, 2009 - pascal-francis.inist.fr
Omalizumab for the treatment of exacerbations in children with inadequately controlled
allergic (IgE-mediated) asthma CNRS Inist Pascal-Francis CNRS Pascal and Francis …
allergic (IgE-mediated) asthma CNRS Inist Pascal-Francis CNRS Pascal and Francis …
Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma.
B Lanier, T Bridges, M Kulus, AF Taylor… - The Journal of Allergy …, 2009 - europepmc.org
Objective This study evaluated the efficacy and safety of omalizumab, a humanized anti-IgE
mAb, in children with moderate-to-severe persistent allergic (IgE-mediated) asthma that was …
mAb, in children with moderate-to-severe persistent allergic (IgE-mediated) asthma that was …
Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma
B Lanier, T Bridges, M Kulus, AF Taylor… - The Journal of Allergy …, 2009 - infona.pl
Many children with asthma continue to experience symptoms despite available therapies.
This study evaluated the efficacy and safety of omalizumab, a humanized anti-IgE mAb, in …
This study evaluated the efficacy and safety of omalizumab, a humanized anti-IgE mAb, in …
Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma
B Lanier, T Bridges, M Kulus, AF Taylor… - The Journal of Allergy …, 2009 - infona.pl
Many children with asthma continue to experience symptoms despite available therapies.
This study evaluated the efficacy and safety of omalizumab, a humanized anti-IgE mAb, in …
This study evaluated the efficacy and safety of omalizumab, a humanized anti-IgE mAb, in …